Myriad Genetics Inc
NASDAQ:MYGN
Wall Street
Price Targets
MYGN Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for
MYGN
is 24.85 USD
with a low forecast of 12.12 USD and a high forecast of 32.55 USD.
MYGN Last Price Targets
Myriad Genetics Inc
The latest public price target was made on Dec 21, 2023 by
David Westenberg
from
Piper Sandler
,
who expects
MYGN
stock to
rise by 27%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Westenberg
Piper Sandler
|
23
USD
Upside 27% |
4 months ago
Dec 21, 2023
|
Genetic Testing Pioneer Myriad Genetics' Evolution Draws Analyst Attention Amid New Product(s) Anticipation
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MYGN's stock price target?
Price Target
24.85
USD
According to Wall Street analysts, the average 1-year price target for
MYGN
is 24.85 USD
with a low forecast of 12.12 USD and a high forecast of 32.55 USD.
What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
9%
For the last 2 years the
compound annual growth rate for
Myriad Genetics Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
9%.
You don't have any saved screeners yet
